• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number H74939295601510
Device Problems Bent (1059); Fracture (1260); Activation, Positioning or Separation Problem (2906)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/26/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Device evaluated by manufacturer: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported the stent was partially deployed.During the deployment of an eluvia¿ drug-eluting vascular stent system, approximately 3-4 centimeters were deployed when the thumbwheel got stuck.The physician had to perform a traction in order to withdraw the sheath.No patient complications were reported.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that the lesion was accessed using a contralateral approach.The lesion was heavily calcified and tortuous.After a non bsc guide sheath and guidewire were advanced the lesion was predilated.During deployment of the eluvia stent, it was noted the stent elongated and fractured.The stent was able to be fully deployed inside the patient with no further intervention need.No patient complications were reported and the patient status was stable.
 
Manufacturer Narrative
Device evaluated by manufacturer: returned product consisted of an eluvia sds with an unidentified.035¿ guidewire and non-bsc guide sheath.The stent was not returned for analysis.The shaft was examined.The middle shaft was buckled 3mm from the markerband.The outer sheath was separated 37cm from the nose cone but remained on the middle sheath.The separated edges were jagged which may have been caused by attempting to cut the outer shaft.The middle sheath had cut marks/damage 37cm-43cm from the nose cone.There was no evidence of any product quality deficiencies.There was a kink at the nose cone.The rack inside the handle was loose.The handle was opened during analysis.The proximal inner and middle sheath were separated from the retainer clip.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event Description
It was further reported that the lesion was accessed using a contralateral approach.The lesion was heavily calcified and tortuous.After a non bsc guide sheath and guidewire were advanced the lesion was predilated.During deployment of the eluvia stent, it was noted the stent elongated and fractured.The stent was able to be fully deployed inside the patient with no further intervention need.No patient complications were reported and the patient status was stable.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that the lesion was accessed using a contralateral approach.The lesion was heavily calcified and tortuous.After a non bsc guide sheath and guidewire were advanced the lesion was predilated.During deployment of the eluvia stent, it was noted the stent elongated and fractured.The stent was able to be fully deployed inside the patient with no further intervention need.No patient complications were reported and the patient status was stable.
 
Manufacturer Narrative
Updated: patient age at time of event : (b)(6) years old.(b)(4).
 
Event Description
It was further reported the target lesion was an occlusion in the superficial femoral artery (sfa).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6123100
MDR Text Key60762108
Report Number2134265-2016-11011
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Pharmacist
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2017
Device Model NumberH74939295601510
Device Catalogue Number39295-60151
Device Lot Number19405926
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/02/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/20/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-